Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SILDENAFIL CITRATE USP (NON-STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 25424.
Remarkably, this DMF maintains an Active status since its submission on November 03, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 12, 2019, and payment made on December 02, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II